LG Chem
051910 · KOSPI · South Korea
Public Market Listing
051910KOSPI
Live quotes, historical charts, and market capitalization for LG Chem are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(4 total)
4Total Assets
0Approved
2Phase 3 / Filed
2Phase 1–2 / Early
4Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
Besifovir dipivoxil (Besivo)No recent activity | Phase 3 | HBV polymerase (reverse transcriptase)Small molecule | Chronic Hepatitis B |
Gemigliptin(Zemiglo) | Phase 3 | DPP-4Small molecule | Type 2 Diabetes |
| Phase 2 | MC4RSmall molecule | Hypothalamic Obesity | |
| Phase 1 | LILRB family receptorMonoclonal antibody | Non-Small Cell Lung Cancer |
Upcoming events
(1 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2028 (1)
April 2028 (1)
Est. primary completion 2028-04-15 · NCT07156578 · CT.gov ↗
What to watch
Financial reports
Annual history (1 year)
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2025-FY | $32.3B | — | — | — | report ↗ |